Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Tables)

v3.22.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted
Stock Units
 
    Number of
shares
subject to
warrants
    Weighted-
average
exercise
price per
share
    Number of
shares
subject to
options
   

Weighted-
average
exercise
price per
share

    Number of shares
subject to
restricted
stock units
 
Balance at December 31, 2020     672,459     $ 8.09       118,388     $ 3.25       2,301,053  
Granted     389,344       2.30      
-
     
-
      894,885  
Exercised     (6,579 )     1.96      
-
     
-
      (884,348 )
Cancelled/Expired     (11,699 )    
-
     
-
     
-
      (150,833 )
Balance at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       2,160,757  
Exercisable at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       1,631,924  

 

    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of
shares
subject to
warrants
    Weighted-
average
exercise
price per
share
    Number of
shares
subject to
options
    Weighted-
average
exercise
price per
share
    Number of
shares
subject to
restricted
stock units
    Weighted-
average
exercise
price per
share
 
Balance at December 31, 2019     1,311,916     $ 9.35       338,595     $ 5.26       630,303     $
          -
 
Granted     146,053       4.51      
-
     
-
      2,222,984      
-
 
Exercised     (681,619 )     5.57       (160,291 )     4.78       (77,234 )    
-
 
Expired     (103,891 )     35.54       (59,916 )     10.55                  
Cancelled/Forfeited    
-
     
-
     
-
     
-
      (475,000 )    
-
 
Balance at December 31, 2020     672,459     $ 8.09       118,388     $ 3.25       2,301,053     $
-
 
Exercisable at December 31, 2020     672,459     $ 8.09       118,388     $ 3.25       2,301,053     $
-
 

 

Schedule of fair value of the warrants as of original issuance date
    Issuance date  
Risk-free interest rate     0.49 - 0.88 %
Expected dividend yield      - %
Expected volatility     100 %
Term     5 years  
Fair value of common stock      1.95 - 2.24  

 

Schedule of company’s Options Outstanding
Warrants Outstanding   Warrants Exercisable

Exercise
Price Rang
e

  Number
Outstanding
    Weighted Average
Remaining
Contractual Life
(in years)
    Weighted
Average
Exercise Price
    Number
Exercisable
  Weighted
Average
Exercise Price
    Intrinsic 
Value
 
$ 1.79 - $20.90     1,043,525       2.98     $ 2.57     1,043,525   $ 2.57      
-
 

 

Options Outstanding   Options Exercisable
Exercise 
Price Range
  Number Outstanding     Weighted 
Average
Remaining
Contractual Life
(in years)
    Weighted
Average
Exercise Price
    Number
Exercisable
  Weighted
Average
Exercise Price
    Intrinsic 
Value
 
$ 2.64 - $28.50     118,388       2.69     $ 3.25     118,388   $ 3.25      
-
 

 

Schedule of stock-based compensation expense
    For the years ended  
    December 31,  
    2021     2020  
Stock-based compensation expense   $ 2,687,901     $ 3,284,570  

 

Schedule of stock-based compensation expense categorized by the equity components
    For the years ended  
    December 31,  
    2021     2020  
Common stock   $ 2,687,901     $ 3,169,470  
Transfer of common stock by founders to contractors    
-
      115,100  
Total   $ 2,687,901     $ 3,284,570